http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7410555

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, Non-P.H.S.
endingPage 818
issn 1535-7163
1538-8514
issueIdentifier 5
pageRange 805-818
publicationName Molecular Cancer Therapeutics
startingPage 805
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a500274ddff6e3ece320321eaa155c72
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6579c6b303ff320ce46d0836fdf4a1e0
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7f0ca8b3a5a76f5cfe2c7b9ae59ac1e1
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8afc3c92190f172f6caca14c475057f8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_90d0d4b89e42136d43be136bb4a8c0f8
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a5567ccd3905b71f555613dded526038
bibliographicCitation Humphries-Bickley T, Castillo-Pichardo L, Hernandez-O'Farrill E, Borrero-Garcia LD, Forestier-Roman I, Gerena Y, Blanco M, Rivera-Robles MJ, Rodriguez-Medina JR, Cubano LA, Vlaar CP, Dharmawardhane S. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer. Mol Cancer Ther. 2017 May;16(5):805–18. PMID: 28450422; PMCID: PMC5418092.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45cd6e219427bc034e4958d3f55394c8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3eac854c7df0b33c345bbc6b7de83a24
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23bace9f086aab0e93df838e5a660168
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0f3910b749193aff9bfc710c43d48dd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f55c0f922fdb6eddd4d9a1bd76ad3da
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e49600df53562af418431590631311db
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5cea61a48711c39e1809f311e59a633
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4a9c16d0f4dc3878e18e318b042644bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c30a9e21e0f1f3be0e04d551ad66de0d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fbe5ee78f58cba8543eb9615ab27ac53
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8b0cd30b76b4157730aa462a7bcdb35
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-5324-109X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_396e7d8a69652f77ed2e57ecf681cb03
date 2017-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1535-7163.mct-16-0442
https://pubmed.ncbi.nlm.nih.gov/28450422
https://pubmed.ncbi.nlm.nih.gov/PMC5418092
isPartOf https://portal.issn.org/resource/ISSN/1538-8514
https://portal.issn.org/resource/ISSN/1535-7163
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer
discusses http://id.nlm.nih.gov/mesh/M0328243
http://id.nlm.nih.gov/mesh/M0003337
http://id.nlm.nih.gov/mesh/M0574421
http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0328159
http://id.nlm.nih.gov/mesh/M0018260
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D020764Q000235
http://id.nlm.nih.gov/mesh/D009389Q000188
http://id.nlm.nih.gov/mesh/D000970Q000494
http://id.nlm.nih.gov/mesh/D001943Q000188
http://id.nlm.nih.gov/mesh/D020764Q000037
http://id.nlm.nih.gov/mesh/D020830Q000235
hasSubjectTerm http://id.nlm.nih.gov/mesh/D020830Q000037
http://id.nlm.nih.gov/mesh/D049109Q000187
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D002465Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D045744
http://id.nlm.nih.gov/mesh/D011743Q000008
http://id.nlm.nih.gov/mesh/D002470Q000187
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D009389Q000473
http://id.nlm.nih.gov/mesh/D001943Q000473
http://id.nlm.nih.gov/mesh/D009389Q000235
http://id.nlm.nih.gov/mesh/D001943Q000235
http://id.nlm.nih.gov/mesh/D002227Q000008
http://id.nlm.nih.gov/mesh/D009362
http://id.nlm.nih.gov/mesh/D015398Q000187
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_132a8504e7423e57e5565c4615cd0cd2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129896932
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51031035
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID998
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5879

Total number of triples: 80.